Metropolis Healthcare Limited has announced that its wholly owned subsidiary, Metropolis Histoxpert Digital Services Private Limited, has entered into a business transfer agreement to acquire Dehradun’s leading diagnostic chain - Dr. Ahujas’ Pathology and Imaging Centre (DAPIC).
DAPIC n operates two laboratories accredited by NABL and NABH, 11 patient service centres, and nine hospital-based centres. It offers a comprehensive range of pathology and soft radiology services, including ultrasound, ECG, and X-ray. In FY 2024-25, DAPIC recorded an estimated annual revenue of Rs 11.5 crore (unaudited), with pathology services contributing 73% and radiology services 27%. With 80 percent of its revenue coming from walk-in patients, the chain has built a strong B2C presence, making it a valuable addition to Metropolis' growing network in North India.
Under the agreement, Metropolis’ wholly owned subsidiary Metropolis Histoxpert Digital Services Private Limited, will acquire 100% ownership of DAPIC in an all-cash deal valued at Rs 35.01 crore. To ensure a seamless transition, DAPIC's founders Dr Alok Ahuja and Dr Alka Ahuja will continue their association with the business post-acquisition.
Commenting on the acquisition, Ameera Shah, Promoter and Executive Chairperson, Metropolis Healthcare Limited, said, “Together with the acquisition of Core Diagnostics, a leader in oncology testing, Scientific Pathology, the dominant chain in Agra, and now DAPIC, the leading diagnostic chain in Dehradun, we are further strengthening our ‘String of Pearls’ strategy—aimed at building a robust and regionally diverse diagnostic network across North India. These strategic moves have expanded the North India contribution to our overall revenues from 8% to an estimated 14–15%. Building on this momentum, we aim to accelerate our expansion across Uttar Pradesh and Uttarakhand—two high-growth markets with significant potential."
